Recent News
FDA approves Amgen’s T cell engager in aggressive form of lung cancer
The FDA on Thursday granted accelerated approval to Amgen’s bispecific T cell engager tarlatamab in small cell lung cancer, an
GSK plans to sell off remaining stake in consumer spinout Haleon
British drugmaker GSK will sell off the rest of its share in Haleon after slowly selling off multibillion-dollar pieces of
Pharma is rethinking how it interacts with patients after Eli Lilly ripped up the playbook
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) More pharma
Supercharge Your Portfolio with Future Health Stocks!
Join us for Profitable Insights & Expert Tips!
Latest Pharma News
FDA approves Amgen’s T cell engager in aggressive form of lung cancer
The FDA on Thursday granted accelerated approval to Amgen’s bispecific T cell engager tarlatamab in small cell lung cancer, an
GSK plans to sell off remaining stake in consumer spinout Haleon
British drugmaker GSK will sell off the rest of its share in Haleon after slowly selling off multibillion-dollar pieces of
Latest Cannabis News
Cresco Labs Q1 Revenue Falls 5%
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results Over 10x year-over-year increase in operating
AYR Wellness Q1 Revenue Flat From a Year Ago
AYR Wellness Reports First Quarter 2024 Results Q1 Revenue up 3% Q/Q to $118.0 Million, Excluding Discontinued Operations Q1 GAAP
Latest biotech News
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024 – Biotech Investments
New York, 05/16/2024 / 09:00, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / May 16,
Live! From the STAT Breakthrough Summit West
On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme
Latest Life Science News
Hunting dogs in Washington show antibodies to H5N1 bird flu virus, study finds
Study found antibodies to H5 and N1 subtype influenza A viruses in 2% of hunting dogs in Washington, suggesting potential
Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival
Latest psychedelics News
Filament Health Announces First Quarter 2024 Financial Results and Operational Highlights | Psychedelic Invest
VANCOUVER, BC, May 14, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural
Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results | Psychedelic Invest
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for
videos
Popular Posts
